A citation-based method for searching scientific literature

Jean-Charles Nault, Massih Ningarhari, Sandra Rebouissou, Jessica Zucman-Rossi. Nat Rev Gastroenterol Hepatol 2019
Times Cited: 53







List of co-cited articles
346 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.
Jessica Zucman-Rossi, Augusto Villanueva, Jean-Charles Nault, Josep M Llovet. Gastroenterology 2015
539
26

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.
Kornelius Schulze, Sandrine Imbeaud, Eric Letouzé, Ludmil B Alexandrov, Julien Calderaro, Sandra Rebouissou, Gabrielle Couchy, Clément Meiller, Jayendra Shinde, Frederic Soysouvanh,[...]. Nat Genet 2015
761
24


Hepatocellular Carcinoma.
Augusto Villanueva. N Engl J Med 2019
852
18

Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.
Jean Charles Nault, Julien Calderaro, Luca Di Tommaso, Charles Balabaud, Elie Serge Zafrani, Paulette Bioulac-Sage, Massimo Roncalli, Jessica Zucman-Rossi. Hepatology 2014
171
18

Sorafenib in advanced hepatocellular carcinoma.
Josep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, Philip Hilgard, Edward Gane, Jean-Frédéric Blanc, Andre Cosme de Oliveira, Armando Santoro, Jean-Luc Raoul, Alejandro Forner,[...]. N Engl J Med 2008
18

Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.
Yasushi Totoki, Kenji Tatsuno, Kyle R Covington, Hiroki Ueda, Chad J Creighton, Mamoru Kato, Shingo Tsuji, Lawrence A Donehower, Betty L Slagle, Hiromi Nakamura,[...]. Nat Genet 2014
407
18

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.
Masatoshi Kudo, Richard S Finn, Shukui Qin, Kwang-Hyub Han, Kenji Ikeda, Fabio Piscaglia, Ari Baron, Joong-Won Park, Guohong Han, Jacek Jassem,[...]. Lancet 2018
16

High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.
Jean Charles Nault, Maxime Mallet, Camilla Pilati, Julien Calderaro, Paulette Bioulac-Sage, Christophe Laurent, Alexis Laurent, Daniel Cherqui, Charles Balabaud, Jessica Zucman-Rossi. Nat Commun 2013
364
16

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
16

Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma.
Wing-Kin Sung, Hancheng Zheng, Shuyu Li, Ronghua Chen, Xiao Liu, Yingrui Li, Nikki P Lee, Wah H Lee, Pramila N Ariyaratne, Chandana Tennakoon,[...]. Nat Genet 2012
537
16


Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial.
Jordi Bruix, Shukui Qin, Philippe Merle, Alessandro Granito, Yi-Hsiang Huang, György Bodoky, Marc Pracht, Osamu Yokosuka, Olivier Rosmorduc, Valeriy Breder,[...]. Lancet 2017
13

Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features.
Daniela Sia, Yang Jiao, Iris Martinez-Quetglas, Olga Kuchuk, Carlos Villacorta-Martin, Manuel Castro de Moura, Juan Putra, Genis Camprecios, Laia Bassaganyas, Nicholas Akers,[...]. Gastroenterology 2017
267
13

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.
Jorge A Marrero, Laura M Kulik, Claude B Sirlin, Andrew X Zhu, Richard S Finn, Michael M Abecassis, Lewis R Roberts, Julie K Heimbach. Hepatology 2018
11

Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.
Ghassan K Abou-Alfa, Tim Meyer, Ann-Lii Cheng, Anthony B El-Khoueiry, Lorenza Rimassa, Baek-Yeol Ryoo, Irfan Cicin, Philippe Merle, YenHsun Chen, Joong-Won Park,[...]. N Engl J Med 2018
707
11

Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.
Jean-Charles Nault, Shalini Datta, Sandrine Imbeaud, Andrea Franconi, Maxime Mallet, Gabrielle Couchy, Eric Letouzé, Camilla Pilati, Benjamin Verret, Jean-Frédéric Blanc,[...]. Nat Genet 2015
237
11

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
Richard S Finn, Shukui Qin, Masafumi Ikeda, Peter R Galle, Michel Ducreux, Tae-You Kim, Masatoshi Kudo, Valeriy Breder, Philippe Merle, Ahmed O Kaseb,[...]. N Engl J Med 2020
739
11

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Andrew X Zhu, Yoon-Koo Kang, Chia-Jui Yen, Richard S Finn, Peter R Galle, Josep M Llovet, Eric Assenat, Giovanni Brandi, Marc Pracht, Ho Yeong Lim,[...]. Lancet Oncol 2019
494
9

Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma.
Jean-Charles Nault, Yoann Martin, Stefano Caruso, Théo Z Hirsch, Quentin Bayard, Julien Calderaro, Cecile Charpy, Christiane Copie-Bergman, Marianne Ziol, Paulette Bioulac-Sage,[...]. Hepatology 2020
45
11

Ageing, telomeres, senescence, and liver injury.
Matthew Hoare, Tapas Das, Graeme Alexander. J Hepatol 2010
90
9

Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis.
Eric Letouzé, Jayendra Shinde, Victor Renault, Gabrielle Couchy, Jean-Frédéric Blanc, Emmanuel Tubacher, Quentin Bayard, Delphine Bacq, Vincent Meyer, Jérémy Semhoun,[...]. Nat Commun 2017
99
9

Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene.
Patrizia Paterlini-Bréchot, Kenichi Saigo, Yoshiki Murakami, Mounia Chami, Devrim Gozuacik, Claude Mugnier, David Lagorce, Christian Bréchot. Oncogene 2003
203
9

Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma.
Cécile Guichard, Giuliana Amaddeo, Sandrine Imbeaud, Yannick Ladeiro, Laura Pelletier, Ichrafe Ben Maad, Julien Calderaro, Paulette Bioulac-Sage, Mélanie Letexier, Françoise Degos,[...]. Nat Genet 2012
864
9

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial.
Anthony B El-Khoueiry, Bruno Sangro, Thomas Yau, Todd S Crocenzi, Masatoshi Kudo, Chiun Hsu, Tae-You Kim, Su-Pin Choo, Jörg Trojan, Theodore H Welling,[...]. Lancet 2017
9

Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.
Sandrine Boyault, David S Rickman, Aurélien de Reyniès, Charles Balabaud, Sandra Rebouissou, Emmanuelle Jeannot, Aurélie Hérault, Jean Saric, Jacques Belghiti, Dominique Franco,[...]. Hepatology 2007
692
9

Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis.
Stefanie U Wiemann, Ande Satyanarayana, Martina Tsahuridu, Hans L Tillmann, Lars Zender, Juergen Klempnauer, Peer Flemming, Sonia Franco, Maria A Blasco, Michael P Manns,[...]. FASEB J 2002
327
9

Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery.
K L Rudolph, S Chang, M Millard, N Schreiber-Agus, R A DePinho. Science 2000
283
9

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma.
Ling-Hao Zhao, Xiao Liu, He-Xin Yan, Wei-Yang Li, Xi Zeng, Yuan Yang, Jie Zhao, Shi-Ping Liu, Xue-Han Zhuang, Chuan Lin,[...]. Nat Commun 2016
122
9

Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma.
Augusto Villanueva, Yujin Hoshida, Carlo Battiston, Victoria Tovar, Daniela Sia, Clara Alsinet, Helena Cornella, Arthur Liberzon, Masahiro Kobayashi, Hiromitsu Kumada,[...]. Gastroenterology 2011
264
7

DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma.
Augusto Villanueva, Anna Portela, Sergi Sayols, Carlo Battiston, Yujin Hoshida, Jesús Méndez-González, Sandrine Imbeaud, Eric Letouzé, Virginia Hernandez-Gea, Helena Cornella,[...]. Hepatology 2015
183
7

Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.
Yujin Hoshida, Sebastian M B Nijman, Masahiro Kobayashi, Jennifer A Chan, Jean-Philippe Brunet, Derek Y Chiang, Augusto Villanueva, Philippa Newell, Kenji Ikeda, Masaji Hashimoto,[...]. Cancer Res 2009
618
7

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
7

Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma.
Ruidong Xue, Ruoyan Li, Hua Guo, Lin Guo, Zhe Su, Xiaohui Ni, Lisha Qi, Ti Zhang, Qiang Li, Zemin Zhang,[...]. Gastroenterology 2016
112
7


Mechanisms of HBV-induced hepatocellular carcinoma.
Massimo Levrero, Jessica Zucman-Rossi. J Hepatol 2016
336
7

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.
Yujin Hoshida, Augusto Villanueva, Masahiro Kobayashi, Judit Peix, Derek Y Chiang, Amy Camargo, Supriya Gupta, Jamie Moore, Matthew J Wrobel, Jim Lerner,[...]. N Engl J Med 2008
885
7

β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma.
Marina Ruiz de Galarreta, Erin Bresnahan, Pedro Molina-Sánchez, Katherine E Lindblad, Barbara Maier, Daniela Sia, Marc Puigvehi, Verónica Miguela, María Casanova-Acebes, Maxime Dhainaut,[...]. Cancer Discov 2019
122
7

Molecular therapies and precision medicine for hepatocellular carcinoma.
Josep M Llovet, Robert Montal, Daniela Sia, Richard S Finn. Nat Rev Clin Oncol 2018
493
7

Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators.
Akihiro Fujimoto, Yasushi Totoki, Tetsuo Abe, Keith A Boroevich, Fumie Hosoda, Ha Hai Nguyen, Masayuki Aoki, Naoya Hosono, Michiaki Kubo, Fuyuki Miya,[...]. Nat Genet 2012
587
7

Senescence surveillance of pre-malignant hepatocytes limits liver cancer development.
Tae-Won Kang, Tetyana Yevsa, Norman Woller, Lisa Hoenicke, Torsten Wuestefeld, Daniel Dauch, Anja Hohmeyer, Marcus Gereke, Ramona Rudalska, Anna Potapova,[...]. Nature 2011
745
7

TERT promoter mutations: gatekeeper and driver of hepatocellular carcinoma.
Roser Pinyol, Victoria Tovar, Josep M Llovet. J Hepatol 2014
30
13

Systematic analysis of telomere length and somatic alterations in 31 cancer types.
Floris P Barthel, Wei Wei, Ming Tang, Emmanuel Martinez-Ledesma, Xin Hu, Samirkumar B Amin, Kadir C Akdemir, Sahil Seth, Xingzhi Song, Qianghu Wang,[...]. Nat Genet 2017
201
7

Hepatocellular carcinoma.
Josep M Llovet, Jessica Zucman-Rossi, Eli Pikarsky, Bruno Sangro, Myron Schwartz, Morris Sherman, Gregory Gores. Nat Rev Dis Primers 2016
972
7

Dual-Mode Ultrasensitive Quantification of MicroRNA in Living Cells by Chiroplasmonic Nanopyramids Self-Assembled from Gold and Upconversion Nanoparticles.
Si Li, Liguang Xu, Wei Ma, Xiaoling Wu, Maozhong Sun, Hua Kuang, Libing Wang, Nicholas A Kotov, Chuanlai Xu. J Am Chem Soc 2016
197
5

Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma.
Paraskevi A Farazi, Jonathan Glickman, Shan Jiang, Alice Yu, Karl Lenhard Rudolph, Ronald A DePinho. Cancer Res 2003
104
5

Liquid biopsy in liver cancer.
Ismail Labgaa, Augusto Villanueva. Discov Med 2015
33
9

High-density single cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinoma.
Delia D'Avola, Carlos Villacorta-Martin, Sebastiao N Martins-Filho, Amanda Craig, Ismail Labgaa, Johann von Felden, Allette Kimaada, Antoinette Bonaccorso, Parissa Tabrizian, Boris M Hartmann,[...]. Sci Rep 2018
27
11

Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma.
Sara Torrecilla, Daniela Sia, Andrew N Harrington, Zhongyang Zhang, Laia Cabellos, Helena Cornella, Agrin Moeini, Genis Camprecios, Wei-Qiang Leow, Maria Isabel Fiel,[...]. J Hepatol 2017
55
5

Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies.
James J Harding, Subhiksha Nandakumar, Joshua Armenia, Danny N Khalil, Melanie Albano, Michele Ly, Jinru Shia, Jaclyn F Hechtman, Ritika Kundra, Imane El Dika,[...]. Clin Cancer Res 2019
133
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.